WikiPatents - Community Patent Review
Create Free Account  |  License or Sell Your Patent  |  WikiPatents Marketplace  |  WikiPatents Blog
Username:  Password:  
    
Advanced Search
Endovascular stent and delivery system    

Custom CD of patents similar to US5100429 : Endovascular stent and delivery system - $19.95
United States Patent5100429   
Link to this pagehttp://www.wikipatents.com/5100429.html
Inventor(s)Sinofsky; Edward L. (Peabody, MA); Boseck; Gary L. (Boxford, MA); McNamara; Edward I. (Chelmsford, MA)
AbstractAn uncured or partially cured, collagen-based material is delivered to a selected site in a blood vessel and is crosslinked in the blood vessel by laser energy or other suitable energy to form an endovascular stent. The collagen-based material can be delivered to the blood vessel as a coating on an inflatable balloon mounted on the distal end of a catheter. The collagen-based material can also be delivered to the blood vessel in liquid form and forced through a porous balloon to form a tubular configuration. The collagen-based material is preferably crosslinked by laser radiation carried through an optical fiber to a diffusing tip located within the balloon. In another embodiment, an endovascular stent is formed by rolling a flexible sheet of biologically-compatible material onto an outside surface of an inflatable balloon. A crosslinkable collagen-based adhesive is used to adhere overlapping portions of the sheet together in the blood vessel and can be used to attach the stent to an inside surface of the blood vessel. The collagen-based adhesive is crosslinked in the blood vessel by application of laser energy or other suitable energy. A photodegradable adhesive can be used on an inside surface of the stent to releasably attach the stent to the inflatable balloon.
   














 Title Information Submit all comments and votes
 
Patent Text Patent PDF Print Page Summary File History
Plain text PDF images Print Summary File History
Drawing from US Patent 5100429
Endovascular stent and delivery system - US Patent 5100429 Drawing
Endovascular stent and delivery system
Inventor     Sinofsky; Edward L. (Peabody, MA); Boseck; Gary L. (Boxford, MA); McNamara; Edward I. (Chelmsford, MA)
Owner/Assignee     C. R. Bard, Inc. (Murray Hill, NJ)
Patent assignment
All assignments
Company News
Publication Date     March 31, 1992
Application Number     07/424,660
PAIR File History     Application Data   Transaction History
Image File Wrapper   Patent Term   Fees
Litigation
Filing Date     October 20, 1989
US Classification     623/1.21 128/DIG.8 604/103.02 604/103.05 606/7
Int'l Classification     A61M 029/02
Examiner     Pellegrino; Stephen C.
Assistant Examiner     Lewis; Ralph A.
Attorney/Law Firm     Wolf, Greenfield & Sacks
Address
Parent Case     CROSS REFERENCE TO RELATED APPLICATION This application is a continuation-in-part of application Ser. No. 345,110 filed Apr. 28, 1989, now abandoned.
Priority Data    
USPTO Field of Search     604/96 604/104 128/DIG. 8 606/191 606/194 606/195 606/7 606/8 606/13 606/14 606/15 623/1 623/12
Patent Tags     endovascular stent delivery
   
Enter a comma (,) or semicolon (;) between multiple tag words/phrases.
Describe this patent:
 Amusing   
 Clever   
 Complex   
 Efficient   
 Historic   
 Important   
 Innovative   
 Interesting   
 Practical   
 Simple   
[no votes]
Patent WIKI

Share information and news about this patent, including information and news about the technology, inventors, company, ligation and licensing.

 References Submit all comments and votes
 
*references marked with an asterisk below are user-added references
 U.S. References
 
Add a new US reference:  
ReferenceRelevancyCommentsReferenceRelevancyComments
3173418



[0 after 0 votes]
3563925



[0 after 0 votes]
3625745



[0 after 0 votes]
3808113



[0 after 0 votes]
4923464
DiPisa, Jr.
606/195
May,1990

[0 after 0 votes]
4878492
Sinofsky
606/7
Nov,1989

[0 after 0 votes]
4877030
Beck
606/195
Oct,1989

[0 after 0 votes]
4799479
Spears
606/28
Jan,1989

[0 after 0 votes]
4773899
Spears
604/20
Sep,1988

[0 after 0 votes]
4763653
Rockey
606/194
Aug,1988

[0 after 0 votes]
4740207
Kreamer
623/1.15
Apr,1988

[0 after 0 votes]
4733665
Palmaz
606/108
Mar,1988

[0 after 0 votes]
4732152
Wallsten
623/1.11
Mar,1988

[0 after 0 votes]
4708718
Daniels
604/507
Nov,1987

[0 after 0 votes]
4704131
Noishiki
600/36
Nov,1987

[0 after 0 votes]
4695281
Miyata
623/23.72
Sep,1987

[0 after 0 votes]
4642118
Kuroyanagi
623/15.12
Feb,1987

[0 after 0 votes]
4641653
Rockey
606/194
Feb,1987

[0 after 0 votes]
4605406
Cahalan
427/2.25
Aug,1986

[0 after 0 votes]
4597762
Walter
600/36
Jul,1986

[0 after 0 votes]
4589882
Urry
623/23.76
May,1986

[0 after 0 votes]
4578067
Cruz, Jr.
602/50
Mar,1986

[0 after 0 votes]
4577631
Kreamer
606/108
Mar,1986

[0 after 0 votes]
4553545
Maass
606/198
Nov,1985

[0 after 0 votes]
4553974
Dewanjee
8/94.11
Nov,1985

[0 after 0 votes]
4503569
Dotter
623/1.19
Mar,1985

[0 after 0 votes]
4485096
Bell
424/532
Nov,1984

[0 after 0 votes]
4478658
Wittwer
156/69
Oct,1984

[0 after 0 votes]
4445892
Hussein
604/101.05
May,1984

[0 after 0 votes]
4423725
Baran
128/207.15
Jan,1984

[0 after 0 votes]
4417576
Baran
128/207.15
Nov,1983

[0 after 0 votes]
4403612
Fogarty
606/194
Sep,1983

[0 after 0 votes]
4378017
Kosugi
424/499
Mar,1983

[0 after 0 votes]
4319363
Ketharanathan
623/1.47
Mar,1982

[0 after 0 votes]
4060081
Yannas
623/15.12
Nov,1977

[0 after 0 votes]
3949073
Daniels
514/2
Apr,1976

[0 after 0 votes]
4390519
Sawyer
424/447
Dec,1969

[0 after 0 votes]
 Foreign References
 Other References
 Market Review Submit all comments and votes
   
Market Size
Estimate the gross annual revenues of the relevant market sector:
> $10B
$5B - $10B
$2B - $5B
$500M - $2B
$100M - $500M
$10M - $100M
$1M - $10M
$500K - $1M
$100K - $500K
< $100K
[No votes]
$0
 
$0   $2.5B   $5B   $7.5B   $10B

[0 market size comments]
Market Share
Estimate the percentage of the relevant market sector this invention will capture:
75% - 100%
50% - 74.99%
25% - 49.99%
10 - 24.99%
5 - 9.99%
2 - 4.99%
1 - 1.99%
< 1%
[No votes]
0.0%
 
0%   25%   50%   75%   100%

[0 market share comments]
Reasonable Royalty
What percentage of gross sales should the inventor or assignee be paid?
75% - 100%
50% - 74.99%
25% - 49.99%
10 - 24.99%
5 - 9.99%
2 - 4.99%
1 - 1.99%
< 1%
[No votes]
0.0%
 
0%   25%   50%   75%   100%

[0 reasonable royalty comments]
Public's "Guesstimation" of Royalty Value
Market SizeN/A[No votes]
xMarket ShareN/A[No votes]
xReasonable RoyaltyN/A[No votes]

N/A

[0 Guesstimation of Royalty Value Comments]
License Availablity
If you are NOT the owner or assignee, answer here:
Yes, license is available for purchase

No, license is not currently available



[No votes]
[0 license availability comments]
License Availablity
If you ARE the owner or assignee, answer here:
Yes, license is available for purchase

No, license is not currently available



[No votes]
[0 owner/assignee comments]
Competitive Advantage
Does this invention have a significant competitive advantage over similar technologies?
Yes

No



[No votes]
Most helpful competitive advantage comment
[No comments]

[0 competitive advantage comments]
Commercial Alternatives
Are there viable commercial alternatives for this invention?
Yes

No



[No votes]
Most helpful commercial alternative comment
[No comments]

[0 commercial alternatives comments]
 Technical Review Submit all comments and votes
 Claims Submit all comments and votes
 


What is claimed is:

1. A method for treating a selected region of a blood vessel, comprising the steps of:

applying a crosslinkable adhesive material to one side of a flexible sheet of biologically-compatible material;

rolling the sheet of biologically-compatible material so that portions of the sheet overlap to form a generally tubular body, said tubular body having said crosslinkable adhesive material between overlapping portions of the sheet;

delivering the tubular body to the selected region of the blood vessel; and

applying energy to the tubular body at the selected region of the blood vessel so as to crosslink the adhesive material and cause overlapping portions of the sheet to adhere together to thereby form a stent in the blood vessel.

2. A method as defined in claim 1 wherein the step of applying a crosslinkable adhesive material includes applying a crosslinkable collagen-based material.

3. A method as defined in claim 1 wherein the step of rolling the sheet of biologically-compatible material includes rolling the sheet onto an outer surface of an inflatable balloon located at or near the distal end of a catheter.

4. A method as defined in claim 3 wherein the step of delivering the tubular body includes advancing the catheter through the blood vessel until the balloon is positioned at the selected region.

5. A method as defined in claim 4 further including the step of inflating the balloon to thereby increase the diameter of the tubular body and urge the tubular body into contact with an inside surface of the blood vessel.

6. A method as defined in claim 1 wherein the step of applying energy includes applying light energy to the tubular body.

7. A method as defined in claim 1 wherein the step of applying energy includes applying diffused laser energy to the tubular body.

8. A method as defined in claim 3 further including the step of applying a photodegradable adhesive to the other side of the sheet of biologically-compatible material prior to the step of rolling the sheet onto an inflatable balloon so that said tubular body is adhered to said inflatable balloon by said photodegradable adhesive.

9. A method as defined in claim 8 wherein the step of applying energy to the tubular body includes applying energy i a first wavelength range selected to degrade said photodegradable adhesive and release said tubular body from said inflatable balloon in the selected region of the blood vessel.

10. A method as defined in claim 9 wherein said photodegradable adhesive includes a fluorescent material that is stimulated by energy in said first wavelength range to emit energy in a second wavelength range required for crosslinking of said crosslinkable adhesive material so that said photodegradable adhesive is degraded by energy in said first wavelength range and said crosslinkable adhesive material is crosslinked by energy emitted by said fluorescent material.

11. A method as define din claim 2 wherein said collagen-based material comprises a collagen containing riboflavin and the step of applying energy includes applying energy int he visible or near-ultraviolet wavelength range.

12. A method as defined in claim 8 wherein said photodegradable adhesive comprises a polyamide.

13. A method as defined in claim 8 wherein said photodegradable adhesive comprises nitrocellulose.

14. A method as defined in claim 10 wherein said fluorescent material comprises a laser dye.

15. A method as defined in claim 1 wherein said sheet has a continuous surface.

16. A method as defined in claim 1 wherein said sheet is patterned with a plurality of openings.

17. A method as defined in claim 1 wherein said crosslinkable adhesive material is applied to an outside surface of said tubular body and wherein the step of applying energy to the tubular body causes the tubular body to be attached to the blood vessel.

18. A combination of a stent and an apparatus for placing a stent in a selected region of a blood vessel, comprising:

a flexible, elongated tube having an inflatable balloon at or near its distal end;

a generally tubular body comprising a sheet of biologically-compatible material rolled onto said balloon so that portions of the sheet overlap, said tubular body having a crosslinkable adhesive material between overlapping portions of the sheet, said tubular body being releaseably adhered to the outside surface of said balloon;

means for inflating said balloon to thereby urge said tubular body into contact with an inside surface of said blood vessel; and

means for applying energy to the tubular body at the selected region of the blood vessel with said balloon inflated so as to crosslink the crosslinkable adhesive material and cause overlapping portions of the sheet to adhere together to thereby form a stent.

19. Apparatus as defined in claim 18 wherein said biologically-compatible material comprises polylactic acid.

20. Apparatus as defined in claim 18 wherein said crosslinkable adhesive material comprises a collagen-based material.

21. Apparatus as defined in claim 20 wherein said collagen-based material comprises a collagen containing riboflavin.

22. Apparatus as defined in claim 18 wherein said means for applying energy includes mean for applying light energy.

23. Apparatus as defined in claim 18 wherein said means for applying energy includes means for applying diffused laser energy.

24. Apparatus as defined in claim 18 wherein said tubular body is releaseably adhered to said balloon with a photodegradable adhesive.

25. Apparatus as defined in claim 24 wherein said photodegradable adhesive comprises a polyamide.

26. Apparatus as defined in claim 24 wherein said photodegradable adhesive comprises nitrocellulose.

27. Apparatus as defined in claim 24 wherein said photodegradable adhesive includes a fluorescent material that is stimulated by energy in a first wavelength range selected to degrade said photodegradable adhesive and release said stent, said fluorescent material emitting energy in a second wavelength range required for crosslinking of said crosslinkable adhesive material when stimulated by energy in said first wavelength range.

28. Apparatus as defined in claim 18 wherein said tubular body has said crosslinkable adhesive material on an outside surface thereof and said means for applying energy to the tubular body causes the tubular body to be attached to the blood vessel.

29. Apparatus as defined in claim 18 wherein said sheet has a continuous surface.

30. Apparatus as defined in claim 18 wherein said sheet is patterned with a plurality of openings.

31. An endovascular stent in a selected region of a blood vessel comprising a tubular body formed as a rolled sheet of biologically-compatible material wherein portions of the sheet overlap, said tubular body having a crosslinked adhesive material between overlapping portions of the sheet.

32. An endovascular stent as defined in claim 31 wherein said biologically-compatible material comprises a polymer.

33. An endovascular stent as defined in claim 31 wherein said biologically compatible material comprises polylactic acid.

34. An endovascular stent as defined in claim 31 wherein said crosslinked adhesive material comprises a collagen-based material.

35. An endovascular stent as defined in claim 34 wherein said collagen-based material comprises a collagen containing riboflavin.

36. An endovascular stent as defined in claim 31 further including a photodegradable adhesive on an inside surface of said tubular body.

37. An endovascular stent as defined in claim 36 wherein said photodegradable material comprises a polyamide.

38. An endovascular stent as defined in claim 36 wherein said photodegradable material comprises nitrocellulose.

39. An endovascular stent as defined in claim 36 wherein said photodegradable adhesive includes a fluorescent material that is stimulated by energy in a first wavelength range selected to degrade said photodegradable adhesive and release said stent, said fluorescent material emitting energy in a second wavelength range required for crosslinking of said crosslinkable adhesive material when stimulated by energy in said first wavelength range.

40. An endovascular stent as defined in claim 31 wherein said tubular body has said crosslinked adhesive material on an outside surface thereof.

41. An endovascular stent as defined in claim 31 wherein said sheet has a continuous surface.

42. An endovascular stent as defined in claim 31 wherein said sheet is patterned with a plurality of openings.

43. An endovascular stent as defined in claim 42 wherein said tubular configuration comprises a plurality of interconnected rings.

44. An endovascular stent as defined in claim 43 wherein interconnected rings have different widths to provide variable flexibility along the length of the stent.
 Description Submit all comments and votes
 


FIELD OF THE INVENTION

This invention relates to an endovascular stent for transluminal delivery to a blood vessel and, more particularly, to an endovascular stent comprising a sheet of biologically-compatible material that is rolled onto an inflatable balloon located at the distal end of a catheter for delivery to a selected site in the blood vessel.

BACKGROUND OF THE INVENTION

Balloon angioplasty is utilized to treat coronary arteries narrowed by plaque deposits. A catheter having an inflatable balloon secured to its distal end is advanced through the artery to the narrowed region. The balloon is inflated, causing the narrowed, or stenosed, region of the artery to be expanded The balloon is then deflated and withdrawn.

A serious problem associated with balloon angioplasty has been the occurrence in up to 30% of the cases of so-called restenosis, either immediately after the procedure or within about six months. Immediate restenosis, also known as abrupt reclosure, results from flaps or segments of plaque and plaque-ridden tissue which are formed during balloon angioplasty and which can block the artery. Such blockage of the artery requires emergency surgery and sometimes results in death. Furthermor